Global Obesity Treatment Market size was valued nearly US$ 7.12 Bn. in 2019 and the total revenue is expected to grow at XX% from 2019 to 2027, reaching nearly US$ XX Bn.
To know about the Research Methodology :- Request Free Sample Report
The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.
Obesity is a disorder characterized by an extreme amount of body fat. The most commonly used principles to assess the existence and the severity of obesity are waist circumference, body mass index, waist-to-height ratio, and the occurrence of the health conditions caused or degenerated by obesity.
Global obesity has increased more than double in the last four decades. Obesity is the second foremost preventable causes of death globally. Treatment of obesity mostly incorporates two-step processes that are management and assessment. Obesity assessment contains the determination of the obesity level and obesity management includes overall maintenance of body weight including the organized weight loss programs. The MMR report contains a detailed study of factors that will drive and restrain the growth of the obesity treatment market. Such as, the global market for obesity treatment is driven by a number of factors like technological advancements in the medical industry, easy obtainability of weight management treatments commercially and many government initiatives concerning overweight issues. As per the world health organization (WHO), about 13% of the global population is categorized as ‘obese’. Weights regain after obesity treatments and high prices are the major hindrances faced by the obesity treatment market globally.
North America obesity treatment market was valued US$ XX Mn. in 2019 and is expected to reach a value of US$ XX Mn. by 2027, with a CAGR of XX.60% during the forecast period. The USA holds major share thanks to the growing obese population influenced by the changing lifestyles in various economies and the increasing spending on R&D and healthcare industry.
Europe holds the second largest share in the obesity treatment market and it is expected to grow at a CAGR of XX.34 % during 2019-2027. Europe aids from the availability of research funds, mounting obese population, and growing adoption of bariatric surgeries.
The MMR report will also provide an accurate prediction of the contribution of the various segments to the growth of the obesity treatment market size. By surgery, the endoscopic procedures segment expected to grow at the highest XX.35% CAGR during the forecast period. This is because of the falling incidences of post-operative infections that stem from non-invasive & invasive procedures.
Major players in the obesity treatment market have taken several strategic measures, such as facility expansions and partnerships. Such as, in 2019, Boehringer Ingelheim Company has cooperated with Gubra group to develop new poly-agonist peptides for the obesity treatment. This will be their second cooperation, which will combine Gubra’s know-how in the synthesis, design, in vivo testing of therapeutic peptides and pharmaceutical description with Boehringer Ingelheim Company in R&D of advanced medicines for cardio metabolic diseases.
The objective of the report is to present a comprehensive analysis of the Global Obesity Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Obesity Treatment Market dynamics, structure by analyzing the market segments and projects the Global Obesity Treatment Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Obesity Treatment Market make the report investor’s guide.
For More Information Visit: https://www.maximizemarketresearch.com/market-report/global-obesity-treatment-market/70599/
Scope of the Global Obesity Treatment Market: Inquire before buying
Global Obesity Treatment Market, By Surgery
• Adjusting gastric Banding
• Roux-en-Y Gastric Bypass
• Sleeve gastrectomy
• Biliopancreatic diversion with Duodenal Switch
• Endoscopic Procedures
Global Obesity Treatment Market, By Drugs
• Appetite suppressants
• Combination drugs
• Satiety drugs
Global Obesity Treatment Market, By End Use
• Beauty institutions
Global Obesity Treatment Market, By Region
• North America
• Asia Pacific
o South Korea
• South America
• Middle East and Africa
o GCC Countries
o South Africa
Key players operating in the Global Obesity Treatment Market
• Olympus Corporation
• F. Hoffmann-La Roche, Ltd.
• Cousin Biotech
• VIVUS, Inc.
• Johnson & Johnson Services, Inc.
• Arena Pharmaceuticals, Inc.
• Orexigen Therapeutics, Inc.
• USGI Medical, Inc.
• Covidien plc
• Mediflex Surgical Products
• EnteroMedics, Inc.
• Novo Nordisk A/S
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your
demand. This report can be personalized to meet your requirements. Get in
touch with us and our sales team will guarantee provide you to get a report that
suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high
growth emerging opportunities & technologies as well as threats to the
companies across the Healthcare, Pharmaceuticals, Electronics &
Communications, Internet of Things, Food and Beverages, Aerospace and
Defense and other manufacturing sectors.